Enhancement of Neprilysin Activity by Natural Polyphenolic Compounds and Their Derivatives in Cultured Neuroglioma Cells.

Alzheimer’s disease aliphatic derivative flavone neprilysin polyphenol

Journal

Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984

Informations de publication

Date de publication:
2023
Historique:
entrez: 1 3 2023
pubmed: 2 3 2023
medline: 4 3 2023
Statut: ppublish

Résumé

The onset of Alzheimer's disease (AD) is characterized by accumulation of amyloid β peptide (Aβ) in the brain. Neprilysin (NEP) is one of the major Aβ-degrading enzymes. Given findings that NEP expression in the brain declines from the early stage of AD before apparent neuronal losses are observed, enhancement of NEP activity and expression may be a preventive and therapeutic strategy relevant to disease onset. We screened for compounds that could enhance the activity and expression of NEP using a polyphenol library previously constructed by our research group and investigated the structure-activity relationships of the identified polyphenols. We found that amentoflavone, apigenin, kaempferol, and chrysin enhanced the activity and expression of NEP, suggesting that chemical structures involving a double bond between positions 2 and 3 in the C ring of flavones are important for NEP enhancement, while catechol or pyrogallol structures, except for the galloyl group of catechins, abolished these effects. Moreover, natural compounds, such as quercetin, were not effective per se, but were changed to effective compounds by adding a lipophilic moiety. Using our study findings, we propose improvements for dietary habits with experimental evidence, and provide a basis for the development of novel small molecules as disease-modifying drugs for AD.

Identifiants

pubmed: 36858574
doi: 10.1248/bpb.b22-00833
doi:

Substances chimiques

Amyloid beta-Peptides 0
Neprilysin EC 3.4.24.11
Apigenin 7V515PI7F6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

446-454

Auteurs

Yuma Hori (Y)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.

Kaori Watanabe (K)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.

Asmaa S A Yassen (ASA)

Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University.
Department of Pharmaceutical Organic Chemistry, Graduate School of Biomedical Sciences, Nagasaki University.

Keiro Shirotani (K)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University.

Takashi Tanaka (T)

Department of Natural Product Chemistry, Graduate School of Biomedical Sciences, Nagasaki University.

Nobuhisa Iwata (N)

Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH